The PACIFIC trial-Where do we go from here in immunotherapy for non-small cell lung cancer?

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)65-66
Number of pages2
JournalEuropean Oncology and Haematology
Volume14
Issue number2
DOIs
StatePublished - 2018

Keywords

  • Durvalumab
  • Immunotherapy
  • Non-small cell lung cancer
  • PACIFIC trial

Cite this